Andrew Yule & CoANDREWYUCorporate

Diversified - Medium / Small Latest results: Mar 2026 13 quarters of data
₹31.35
MCap ₹1,533 Cr
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹93 Cr
Sales · Mar 2026
-5.6% YoY
₹-48 Cr
Operating Profit · Mar 2026
-13.8% YoY
-51.6%
OPM % · Mar 2026
-20.6% YoY
₹-43 Cr
Net Profit · Mar 2026
-250.8% YoY
₹-0.88
EPS · Mar 2026
-252.0% YoY

📝 Andrew Yule & Co — results explained

Quarter ended March 2026 (Q4 FY26)

Andrew Yule & Co reported revenue of ₹93 crore for the quarter ended March 2026 (Q4 FY26), down 5.6% from ₹98 crore in the same quarter last year, and up 24.2% sequentially over the December 2025 quarter.

The company reported a net loss of ₹43 crore, against a net loss of ₹12 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.88.

Operating profit stood at ₹-48 crore — an operating margin (OPM) of -51.6%, compared with -42.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Andrew Yule & Co posted revenue of ₹296 crore, a decline of 5.2% over FY25, with a net loss of ₹31 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹296 crore with a net loss of ₹31 crore.

Valuation snapshot

At the current price of ₹31.35, ANDREWYU has a market capitalisation of ₹1,533 crore.

Within the Diversified - Medium / Small industry, it is the 2nd-largest of the 8 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 89.25%, foreign institutional investors (FIIs) 0.00%, domestic institutional investors (DIIs) 2.20%, the government 0.00%, public shareholders 8.55% of Andrew Yule & Co.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,533 Cr
Current Price ?
₹31.4
P/E ?
N/A
Industry P/E ?
13.10
P/B ?
20.17
P/S ?
5.19
P/FCF ?
-15.64
Enterprise Value ?
₹1,654 Cr
EV/EBITDA ?
-17.59
PEG ?
N/A
Earnings Yield ?
-6.1%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹296 Cr
OPM ?
-31.8%
Profit after tax (TTM) ?
₹-31 Cr
EPS (TTM) ?
₹-0.64
ROCE ?
-7.0%
ROE ?
-41.1%
ROA ?
-6.3%
Growth
Sales — latest qtr ?
₹93 Cr
PAT — latest qtr ?
₹-43 Cr
YoY qtr sales growth ?
-5.6%
YoY qtr profit growth ?
-250.8%
Sales growth (3y) ?
-8%
Sales growth (5y) ?
-2%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹121 Cr
Debt to Equity ?
1.59
Interest Coverage ?
-4.9
Current Ratio ?
N/A
Ownership
Promoter holding ?
89.25%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
2.3%
Return 6 months ?
32.9%

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 815,8588887775689689856727593 -5.6% +24.2%
Operating Profit -16-2,080-12-21-35-1210-20-42-28-5-14-48 -13.8% -248.5%
Other Income 91,001812951111366011107 -80.7% -27.4%
Interest 332534555485456 -23.7% +12.6%
Depreciation 219011222222222 +12.1% +21.0%
Profit Before Tax -12-1,595-9-15-33-1315-15-16260-11-50 -222.5% -350.0%
Net Profit -11-1,595-7-13-28-1213-14-1224-1-11-43 -250.8% -307.2%
EPS -0.22-0.33-0.15-0.27-0.57-0.250.27-0.28-0.250.48-0.03-0.22-0.88 -252.0% -300.0%
OPM % -19.8% -35.5% -13.8% -24.6% -45.5% -21.2% 11.3% -28.8% -42.8% -49.3% -6.4% -18.4% -51.6% -20.6% -180.4%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹312 Cr ₹296 Cr ₹296 Cr -5.2%
Operating Profit ₹-64 Cr ₹-94 Cr ₹-94 Cr -48.0%
OPM % -20.37% -31.82% -31.82% -56.2%
NPM % -8.19% -10.57% -10.57% -29.1%
Other Income ₹64 Cr ₹87 Cr ₹87 Cr +37.6%
Depreciation ₹7 Cr ₹7 Cr ₹7 Cr +3.2%
Interest ₹22 Cr ₹21 Cr ₹21 Cr -5.4%
EBIT ₹-70 Cr ₹-101 Cr ₹-101 Cr -43.8%
PBT ₹-28 Cr ₹-35 Cr ₹-35 Cr -23.5%
Tax ₹-2 Cr ₹4 Cr ₹4 Cr +334.4%
Net Profit ₹-26 Cr ₹-31 Cr ₹-31 Cr -22.4%
EPS ₹-0.51 ₹-0.65 ₹-0.65 -27.5%
Material Cost ₹111 Cr ₹94 Cr ₹94 Cr -15.2%
Employee Cost ₹198 Cr ₹150 Cr ₹150 Cr -24.2%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 98989898 +0.0%
Reserves 89263-22 -833.3%
Borrowings 100114105121 +15.2%
Other Liabilities 257257308302 -1.9%
Total Liabilities 543496514499 -2.9%
Fixed Assets 142162192207 +7.8%
CWIP 94886145 -26.2%
Investments 3365 -16.7%
Other Assets 305242256243 -5.1%
Total Assets 543496514499 -2.9%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 43-4-23-92 -300.0%
Cash from Investing Activity -17598376 -8.4%
Cash from Financing Activity -8-15-2216 +172.7%
Net Cash Flow 183938-0 -100.0%
Free Cash Flow -4-19-8-98 -1125.0%
CFO/OP -684%5%36%98% +172.2%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 115118146108 -26.0%
Inventory Days 155109134166 +23.9%
Days Payable 304246351239 -31.9%
Cash Conversion Cycle -33-19-7135 +149.3%
Working Capital Days -53-153-187-242 -29.4%
ROCE % 6%-24%-14%-7% +50.0%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 89.25%89.25%89.25%89.25% +0.0%
FIIs 0.00%0.00%0.00%0.00% —
DIIs 2.20%2.20%2.20%2.20% +0.0%
Government 0.00%0.00%0.00%0.00% —
Public 8.54%8.55%8.54%8.55% +0.1%
No. of Shareholders 47,40047,11546,60145,469 -2.4%

⚖️ Peer comparison

Industry: Diversified - Medium / Small · 8 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 TTKHLTCARE TTK Healthcare ₹1,007.10 1,423 21.7 857 66 3.0% 7.7% 7.0% -19.5% 14.7% 37.5%
2 ANDREWYU Andrew Yule ₹26.11 1,277 0.7 5,854 1,974 -48.4% 33.7% 0.8% 839.4% -5.5% -5020.6%
3 BCLIND Bcl Industries ₹33.96 1,002 8.6 2,622 129 9.5% 4.9% 6.2% 29.8% -21.3% 7.6%
4 TARACHAND Tara Chand ₹45.67 360 15.7 291 23 34.7% 7.9% 20.7% 42.4% 10.7% -74.0%
5 SPECTSTM Spectrum Talent ₹109.80 254 20.7 1,450 12 1.0% 0.8% — — 0.4% 253.9%
6 GILLANDERS Gillanders Arbuthnot ₹103.00 220 12.6 434 17 6.9% 4.0% -2.8% -64.6% 3.3% 146.2%
7 VIKASECO Vikas EcoTech ₹1.05 146 75.8 369 3 1.6% 0.8% -6.5% -81.5% 15.1% -15.6%
8 INDIFRA Indifra ₹33.70 25 n/m 17 0 -1.8% 0.1% — — 582.5% 157.7%
❓ Frequently asked questions
What was Andrew Yule & Co's revenue in Q4 FY26?
Andrew Yule & Co reported revenue of ₹93 crore for the quarter ended March 2026 (Q4 FY26), down 5.6% from ₹98 crore in the same quarter last year, and up 24.2% sequentially over the December 2025 quarter.
What was Andrew Yule & Co's net profit in Q4 FY26?
The company reported a net loss of ₹43 crore, against a net loss of ₹12 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.88.
What is ANDREWYU's market capitalisation and P/E ratio?
At the current price of ₹31.35, ANDREWYU has a market capitalisation of ₹1,533 crore.
Who owns Andrew Yule & Co? (shareholding pattern)
As of Mar 2026, promoters held 89.25%, foreign institutional investors (FIIs) 0.00%, domestic institutional investors (DIIs) 2.20%, the government 0.00%, public shareholders 8.55% of Andrew Yule & Co.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI